Targeting MUC1-Mediated Tumor-Stromal Metabolic Interaction in Triple-Negative Breast Cancer
Abstract
Mucin1 (MUC1), a glycoprotein is aberrantly overexpressed in TNBC and facilitates growth and metastasis of triple negative breast cancer (TNBC) cells. This occurrence can be partially attributed to MUC1 interaction with hypoxia-inducible factor alpha (HIF1 ), a key regulator of glycolysis. We previously observed that ectopic overexpression of MUC1 increased glucose uptake, lactate secretion and enhanced the expression of glycolytic enzymes. Therefore we hypothesized that MUC1 stabilizes HIF1 to facilitate metabolic reprogramming. In the present study MUC1-overexpressing cells (MDA-MB-231.MUC1) demonstrated that MUC1 alters expression of several metabolic genes. Metabolic gene alterations was also observed in MUC1 compared to Neo after stimulating cells with EGF, which induces nuclear localization and transcriptional activation of the cytoplasmic tail of MUC1. Additionally, MUC1 enhanced glutamine uptake that was increased/decreased under hypoxic conditions and increased nucleotide biosynthesis to support cell growth. Lastly, MUC1 increased/decreased oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), indicative of cells utilizing glycolysis and/or oxidative phosphorylation to meet energy requirements. Thus our results support the notion that MUC1 serves as a metabolic regulator in TNBC, facilitating metabolic reprogramming that influences growth of TNBC.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2014
- Accession Number
- ADA612567
Entities
People
- Pankaj K Singh
Organizations
- University of Nebraska Omaha